Page last updated: 2024-09-03

gefitinib and diacetyldichlorofluorescein

gefitinib has been researched along with diacetyldichlorofluorescein in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (diacetyldichlorofluorescein)	Trials (diacetyldichlorofluorescein)	Recent Studies (post-2010) (diacetyldichlorofluorescein)
5,231	566	2,919	429	1	148

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, H; Liao, K; Zi, Y	1

Other Studies

1 other study(ies) available for gefitinib and diacetyldichlorofluorescein

Article	Year
[Cigarette Smoke Induces Gefitinib Resistance in NSCLC Cells  via ROS/Sirt3/SOD2 Pathway]. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2023, Apr-20, Volume: 26, Issue:4 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cigarette Smoking; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Reactive Oxygen Species; Sincalide; Sirtuin 3	2023

Article

Year

[Cigarette Smoke Induces Gefitinib Resistance in NSCLC Cells  via ROS/Sirt3/SOD2 Pathway].

Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2023, Apr-20, Volume: 26, Issue:4

Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cigarette Smoking; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Reactive Oxygen Species; Sincalide; Sirtuin 3

2023